| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. (VERA) has 18 insiders with recent SEC Form 4 filings, including 12 buys and 1 sell. VERA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 137.5K | $4.98M | - | |
| Other | 53.1K | $1.92M | - | |
| Other | 50.0K | $1.81M | - | |
| CFO | 50.0K | $1.81M | - | |
| Other | 49.1K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | Grant Sean52 | Chief Financial Officer | Buy | 5,000 | $13.60 | $68,004.00 | New | +49.4% | -9.1% | |
| May 31, 2022 | Curley Joanne69 | Chief Development Officer | Sale+OE | 400 | $15.22 | $6,086.20 | -1.6% | +50.1% | -42.6% | |
| Feb 10, 2022 | Longitude Capital Partners Iv, LLC63 | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| Feb 10, 2022 | Enright Patrick G74 | Director, 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| Feb 10, 2022 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 266,666 | $15.00 | $3,999,990.00 | +9.1% | -14.9% | -58.0% | |
| Feb 6, 2022 | Young Joseph R58 | SVP, Finance, Chief Acct Offcr | Buy | 5,714 | $7.00 | $39,998.00 | +33.7% | -9.1% | -65.8% | |
| Feb 6, 2022 | Grant Sean52 | Chief Financial Officer | Buy | 14,285 | $7.00 | $99,995.00 | +40.1% | -9.1% | -65.8% | |
| May 18, 2021 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| May 18, 2021 | Katabi Maha71 | Director, 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| May 18, 2021 | Enright Patrick G74 | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% |